BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32424582)

  • 1. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
    Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis.
    Ergenç M; Uprak TK; Akın Mİ; Hekimoğlu EE; Çelikel ÇA; Yeğen C
    BMC Surg; 2023 Aug; 23(1):220. PubMed ID: 37550669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Lymph Node Staging Systems as Independent Prognosticators in Remnant Gastric Cancer Patients with an Insufficient Number of Harvested Lymph Nodes.
    Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Takahashi K; Maezawa Y; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Cho H; Yukawa N; Yoshikawa T; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2021 May; 28(5):2866-2876. PubMed ID: 33393020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Komori K; Tamagawa A; Nakazano M; Hara K; Hashimoto I; Tamagawa H; Segami K; Maezawa Y; Kano K; Oshima T; Yukawa N; Rino Y
    In Vivo; 2022; 36(2):994-1000. PubMed ID: 35241561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Lymph Node Ratio in Locally Advanced Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Kano K; Yamada T; Komori K; Watanabe H; Takahashi K; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2021 Dec; 28(13):8464-8472. PubMed ID: 34114182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the metastatic lymph node ratio compared to the TNM classification in stage III gastric cancer.
    Gulmez S; Senger AS; Uzun O; Omeroglu S; Ofluoglu C; Sert ZO; Oz A; Polat E; Duman M
    Niger J Clin Pract; 2021 Nov; 24(11):1602-1608. PubMed ID: 34782497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate Risk Stratification of Patients with Node-Positive Gastric Cancer by Lymph Node Ratio.
    Nakamura S; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    World J Surg; 2020 Dec; 44(12):4184-4192. PubMed ID: 32892273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
    BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of lymph node ratio for local advanced gastric cancer patients with adjuvant chemoradiotherapy after D2 gastrectomy.
    Hu M; Zhang S; Yang X; Shen Y; Li Z; Zhao Y; Xu F; Jiang D; Wang X; Wang Y
    Medicine (Baltimore); 2018 Nov; 97(44):e13079. PubMed ID: 30383693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
    Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
    J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.
    Hou Y; Wang X; Chen J
    World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Yang H; Mei T
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of regional positive lymph node ratio of gallbladder carcinoma on prognosis].
    Zhou YM; Mi HC; Jiang W; Jiang Y; Hua YF; Lu CJ; Wang CN; Lu CD
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1202-1207. PubMed ID: 36380669
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer.
    Hong SA; Son MW; Cho J; Lee CH; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee KT; Lee MS
    Medicine (Baltimore); 2018 Jan; 97(3):e9703. PubMed ID: 29505025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.
    Yukawa N; Aoyama T; Tamagawa H; Tamagawa A; Atsumi Y; Kawahara S; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Masuda M; Rino Y
    In Vivo; 2020; 34(4):2087-2093. PubMed ID: 32606187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
    Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby DA; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
    Ann Surg; 2015 Dec; 262(6):991-8. PubMed ID: 25563867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.